Recs

30

Balanced Biomet: Fool by Numbers

On Jan. 19, Biomet (Nasdaq: BMET  ) released second-quarter earnings for the period ended Nov. 30.

  • Net sales increased 5.2%, primarily driven by 9.4% growth in revenues from reconstructive products.
  • Accounts receivable and inventory growth outpaced sales growth. That can be a troubling sign if it recurs several quarters in a row.
  • On Dec. 18, the company announced that it would be taken off the market by a private equity group for $10.9 billion, or $44 per share in cash.

(Figures in millions, except per-share data)

Income Statement Highlights

Q2 2007

Q2 2006

Change

Sales

$520.3

$494.7

5.2%

Net Profit

$103.2

$101.3

1.9%

EPS

$0.42

$0.41

2.4%

Diluted Shares

245.1

249.3

(1.7%)



Get back to basics with a look at the income statement.

Margin Checkup

Q2 2007

Q2 2006

Change*

Gross Margin

70.9%

71.8%

(0.9)

Operating Margin

29.6%

30.8%

(1.2)

Net Margin

19.8%

20.5%

(0.6)

*Expressed in percentage points.

Margins are the earnings engine. See how they work.

Balance Sheet Highlights

Assets

Q2 2007

Q2 2006

Change

Cash + ST Invest.

$105.0

$106.5

(1.4%)

Accounts Rec.

$554.3

$479.9

15.5%

Inventory

$563.2

$495.6

13.6%



Liabilities

Q2 2007

Q2 2006

Change

Accounts Payable

$56.9

$58.1

(2.1%)

Long-Term Debt

$0.0

$0.0

N/A



Learn the ways of the balance sheet.

Cash Flow Highlights

YTD 2007

YTD 2006

Change

Cash From Ops.

$127.8

$178.9

(28.5%)

Capital Expenditures

$52.7

$50.7

4.0%

Free Cash Flow

$75.2

$128.2

(41.4%)



Find out why Fools always follow the money.

Related Companies:

  • Medtronic (NYSE: MDT  )
  • Zimmer Holdings (NYSE: ZMH  )
  • St. Jude Medical (NYSE: STJ  )
  • Smith & Nephew (NYSE: SNN  )
  • Varian Medical Systems (NYSE: VAR  )

Related Foolishness:

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 520968, ~/Articles/ArticleHandler.aspx, 5/27/2012 9:39:03 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2012 4:01 PM
VAR $61.36 Up +0.21 +0.34%
Varian Medical Sys… CAPS Rating: ****
ZMH $62.04 Up +0.14 +0.23%
Zimmer Holdings, I… CAPS Rating: ****
STJ $39.43 Up +0.14 +0.36%
St. Jude Medical,… CAPS Rating: ****
MDT $36.88 Down -0.19 -0.51%
Medtronic, Inc. CAPS Rating: *****
SNN $47.26 Up +0.21 +0.45%
Smith & Nephew CAPS Rating: ****

Advertisement